Poland· PL-100422360

Prostamol uno

A sabalis serrulatae fructus, inkl. kombinationspräparate product containing sabalis serrulatae fructus extractum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.

ATC G04CX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedProstamol unoATCG04CX02REGISTER NO.PL-100422360PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Sabalis serrulatae fructus, inkl. kombinationspräparate is registered in 7 of 19 countries.

Countries holding a registration under ATC G04CX02 (sabalis serrulatae fructus, inkl. kombinationspräparate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Sabalis serrulatae fructus, inkl. kombinationspräparate · ATC G04CX02

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sabalis serrulatae fructus extractum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
G04CX02
ATC class
Sabalis serrulatae fructus, inkl. Kombinationspräparate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991407674
  • gtin
    05909991407681
  • gtin
    05909991407698

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sabalis serrulatae fructus, inkl. kombinationspräparate in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sabalis serrulatae fructus, inkl. kombinationspräparate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Austria · Prostasan
  • Belgium · Prosta-Urgenin
  • France · Palmier De Floride Pharmatoka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2359a45b-2743-4ffe-b38d-e1fbb337fcda
GET /v1/drugs/2359a45b-2743-4ffe-b38d-e1fbb337fcda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "320 mg",
  "packaging": "05909991407674 ¦ OTC ¦ 133182\n30 kaps.\n05909991407681 ¦ OTC ¦ 133183\n60 kaps.\n05909991407698 ¦ OTC ¦ 133184\n90 kaps.",
  "substance": null,
  "common_name": "Sabalis serrulatae fructus extractum",
  "pl_product_id": "100422360",
  "pozwolenie_nr": "235/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-06-24"
}

See everything about sabalis serrulatae fructus, inkl. kombinationspräparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.